Item 5. Market for Registrant’s Common Equity
Item
5.
Market
for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.
(a)
Market
Information
Our
public shares and rights are each currently traded on the Nasdaq Capital Market under the symbols “DMAQ” and “DMAQR”,
respectively. Our units traded on the Nasdaq Global Market under the symbol “DMAQU”. However, on December 2, 2021, the units
ceased public trading, and the public shares and rights underlying the units commenced trading separately on the Nasdaq Global Market.
On
February 15, 2023, we received approval from the Nasdaq Listing Qualifications Department of Nasdaq that our application to transfer
the listing of the public shares and rights from the Nasdaq Global Market to the Nasdaq Capital Market was approved. The public shares
and rights were transferred to the Nasdaq Capital Market at the opening of business on February 17, 2023 and continue to trade under
the symbol “DMAQ” and “DMAQR,” respectively. The Nasdaq Capital Market operates in substantially the same manner
as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq’s corporate governance
requirements.
(b)
Holders
On
May 26, 2023, there were 8 holders of record of our Class A common stock and 1 holder of record of our rights.
(c)
Dividends
We
have not paid any cash dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of our initial
business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements
and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent
to our initial business combination will be within the discretion of our board of directors at such time. In addition, our board of directors
is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future. Further, if we incur
any indebtedness in connection with our initial business combination, our ability to declare dividends may be limited by restrictive
covenants we may agree to in connection therewith.
(d)
Securities
Authorized for Issuance Under Equity Compensation Plans
None.
(e)
Recent
Sales of Unregistered Securities
On
December 23, 2022, we held the 2022 Special Meeting at which our stockholders approved, among other things, an amendment to our amended
and restated certificate of incorporation to provide for the right of a holder of Class B common stock to convert into Class A common
stock on a one-for-one basis prior to the closing of an initial business combination.
Also
on December 23, 2022, stockholders holding all of the issued and outstanding Class B common stock elected to convert their Class B common
stock into Class A common stock on a one-for-one basis. As a result, 3,162,500 shares of Class B common stock were cancelled, and 3,162,500
shares of Class A common stock were issued to such holders of the converting Class B common stock.
(f)
Use
of Proceeds from the Initial Public Offering
For
a description of the use of proceeds generated in our initial public offering and private placement, see Part II, Item 2 of our Quarterly
Report on Form 10-Q for the quarterly period ended September 30, 2021, as filed with the SEC on November 15, 2021. There has been no
material change in the planned use of proceeds from our initial public offering and private placement as described in the IPO Registration
Statement. The specific investments in our trust account may change from time to time.
28
(g)
Purchases
of Equity Securities by the Issuer and Affiliated Purchasers
On
December 23, 2022, we held the 2022 Special Meeting at which our stockholders approved, among other things, an amendment to our amended
and restated certificate of incorporation to extend the date by which we must consummate an initial business combination to July 29,
2023, or such earlier date as determined by the board of directors. In connection with the vote to approve the Second Extension, the
holders of 11,819,790 public shares properly exercised their right to redeem such shares for a pro rata portion of the funds in the trust
account. As a result, approximately $121 million (approximately $10.24 per share) was removed from the trust account to pay such holders.
There
were no such repurchases of our equity securities by us or an affiliate during the fourth quarter of the fiscal year covered by the Report.
Item
6.
[Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.